Physiomics Clarifies Merck Deal Value
November 30 2017 - 9:31AM
Dow Jones News
By Oliver Griffin
Shares in Physiomics PLC (PYC.LN) soared on Thursday, prompting
the company to clarify the value of its recently announced contract
with Merck KGaA (MRK.XE).
On Nov. 28, Physiomics said that it had entered into a
multi-year services agreement with Merck--a deal that is worth a
minimum of 500,000 euros ($592,542) in the first 12 months.
Following the movement in its share price, Physiomics said it
would like to confirm that this represents the expected value of
the contract in the first twelve months, adding that there is no
guarantee that it will be higher than this.
Physiomics said it would also like to confirm that the contract
envisages a multi-year agreement with no specific term and that the
annual value of services provided under the contract after the
first year is not guaranteed.
Shares at 1352 GMT were up 12.13 pence, at 21.63 pence.
Write to Oliver Griffin at oliver.griffin@dowjones.com
(END) Dow Jones Newswires
November 30, 2017 09:16 ET (14:16 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Physiomics (LSE:PYC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Physiomics (LSE:PYC)
Historical Stock Chart
From Apr 2023 to Apr 2024